Search

Author/Creator Huang, Tina C.

1. Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities. (March 2019)

Authors:
Sverak, Pavlina; Adams, Meredith E.; Haines, Stephen J.; Levine, Samuel C.; Nascene, David; Sommer, Katherine; Dusenbery, Kathryn; Huang, Tina C.; Moertel, Christopher
Journal:
Otolaryngology--head and neck surgery
Issue:
Volume 160:Number 3(2019)
Page Start:
526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient‐Reported Outcomes and Toxicities. (30th October 2018)

Authors:
Sverak, Pavlina; Adams, Meredith E.; Haines, Stephen J.; Levine, Samuel C.; Nascene, David; Sommer, Katherine; Dusenbery, Kathryn; Huang, Tina C.; Moertel, Christopher
Journal:
Otolaryngology--head and neck surgery
Issue:
Volume 160:Number 3(2019)
Page Start:
526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search